Table 3 Joint Effects for DVT between ESRD and Associated Risk Factors (n = 3564, IR = 5.6%)
From: Increased risk of deep vein thrombosis in end-stage renal disease patients
Variable | Number (%) | Events | Rate | aHR (95% CI) | P |
|---|---|---|---|---|---|
Age > =50 years | 2893 (81.20) | 167 | 0.06 | 1.65 (1.13–2.40) | 0.01 |
Hypertension | 2024 (56.80) | 125 | 0.06 | 1.10 (0.83–1.47) | 0.52 |
Diabetes | 1404 (39.39) | 89 | 0.06 | 1.26 (0.95–1.67) | 0.11 |
Hyperlipidemia | 208 (5.84) | 19 | 0.09 | 1.73 (1.08–2.78) | 0.02 |
Cerebrovascular accident | 394 (11.05) | 18 | 0.05 | 0.90 (0.56–1.47) | 0.68 |
Congestive heart failure | 616 (17.28) | 30 | 0.05 | 1.04 (0.70–1.53) | 0.86 |
Atrial fibrillation | 64 (1.80) | 2 | 0.03 | 0.77 (0.19–3.10) | 0.71 |
Lower leg fracture or surgery | 44 (1.23) | 4 | 0.09 | 2.04 (0.76–5.48) | 0.16 |
Cancer | 82 (2.30) | 3 | 0.04 | 0.89 (0.28–2.78) | 0.84 |
≥1 comorbidity | 2547 (71.46) | 151 | 0.06 | 1.14 (0.83–1.58) | 0.43 |
≥2 comorbidities | 1509 (42.34) | 88 | 0.06 | 1.13 (0.86–1.50) | 0.39 |
≥3 comorbidities | 630 (17.68) | 43 | 0.07 | 1.45 (1.03–2.03) | 0.03 |